Skip to content

Contribution of Image Fusion in Percutaneous Left Atrial Occlusion procédures (Fusion Image)

Contribution of Image Fusion in Percutaneous Left Atrial Occlusion Procedures

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03961490
Enrollment
10
Registered
2019-05-23
Start date
2017-06-09
Completion date
2018-05-15
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Atrial fibrillation is the most common rhythm disorder, affecting 2 to 3 percent of the population. One of the major complications is the occurrence of thromboembolic events, the thromboembolic risk can be predicted by the ChadsVasc score. Anticoagulant treatment is therefore almost always indicated, however, in view of the target population, anticoagulant treatment is sometimes contraindicated, justifying the appearance of alternative treatment such as occlusion of the left auricle by surgical or percutaneous means, with the placement of a prosthesis in the left auricle. Image fusion is a new imaging technique aimed at improving the spatial view of 2D images (made during a catheterization session) by repositioning in real time a 3D model obtained by reconstruction from scanner images of the structure of interest. Once the model has been redesigned, it follows all the consequences that the hemodynamicist wants to take and thus guides the gesture as well as possible. The purpose of this project is to evaluate the contribution of image fusion to per cutaneous occlusion procedures of the left atrium. This contribution will be evaluated by comparing the procedure time, the irradiation time, the amount of contrast material used between the procedures performed with the image fusion technique and without this new technique.

Interventions

No interventional study

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Major patient * Patient with a collegially selected indication of FAG * Patient willing to participate in the study

Exclusion criteria

* Minors, adults under guardianship and protected persons * Presence of contraindications to the procedure, including the presence of a thrombus in the left atrium * Procedure combined with another percutaneous gesture at the same time

Design outcomes

Primary

MeasureTime frameDescription
evaluate the contribution of image fusion to reduce patient irradiation with measurement of the amount of irradiation of the procedure3 yearsthe cumulative Air KERMA in milligray (mGy)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026